Isabelle Fichtenbauer 1 , Stefan Priebe 2 , Beate Schrank 1 Show Affiliations »
Abstract
OBJECTIVE: The pilot study aimed to apply and evaluate the German version of DIALOG+ in patients with psychosis. METHODS: The German version of DIALOG+ was used with ten patients with psychosis in five sessions each over a 8-week period. DIALOG+ is a brief intervention that is supported by an App, structures clinical routine consultations and helps patients to define and achieve personal goals. For evaluating outcomes, symptom levels, disability and subjective quality of life before and after treatment were compared. RESULTS: Adherence was high with a total of 49 of 50 planned sessions completed. Patients showed significant improvements in schizophrenia symptoms (d = 0.88), depressive symptoms (d = 0.85), everyday impairment (d = 0.83) and subjective quality of life (d = 0.12). CONCLUSION: The German version of DIALOG+ provides a feasible and promising approach to make routine meetings therapeutically effective. © Georg Thieme Verlag KG Stuttgart · New York.
OBJECTIVE: The pilot study aimed to apply and evaluate the German version of DIALOG+ in patients with psychosis. METHODS: The German version of DIALOG+ was used with ten patients with psychosis in five sessions each over a 8-week period. DIALOG+ is a brief intervention that is supported by an App, structures clinical routine consultations and helps patients to define and achieve personal goals. For evaluating outcomes, symptom levels, disability and subjective quality of life before and after treatment were compared. RESULTS: Adherence was high with a total of 49 of 50 planned sessions completed. Patients showed significant improvements in schizophrenia symptoms (d = 0.88), depressive symptoms (d = 0.85), everyday impairment (d = 0.83) and subjective quality of life (d = 0.12). CONCLUSION: The German version of DIALOG+ provides a feasible and promising approach to make routine meetings therapeutically effective. © Georg Thieme Verlag KG Stuttgart · New York.
Entities: Chemical
Mesh： See more »
Year: 2019
PMID： 31412369 DOI： 10.1055/a-0961-3328
Source DB: PubMed Journal: Psychiatr Prax ISSN： 0303-4259